Literature DB >> 17622968

Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents.

Toshiki Tanaka1, Xuan Huang, H Dorota Halicka, Hong Zhao, Frank Traganos, Anthony P Albino, Wei Dai, Zbigniew Darzynkiewicz.   

Abstract

This review covers the topic of cytometric assessment of activation of Ataxia telangiectasia mutated (ATM) protein kinase and histone H2AX phosphorylation on Ser139 in response to DNA damage, particularly the damage that involves formation of DNA double-strand breaks. Briefly described are molecular mechanisms associated with activation of ATM and the downstream events that lead to recruitment of DNA repair machinery, engagement of cell cycle checkpoints, and activation of apoptotic pathway. Examples of multiparameter analysis of ATM activation and H2AX phosphorylation vis-a-vis cell cycle phase position and induction of apoptosis that employ flow- and laser scanning-cytometry are provided. They include cells treated with a variety of exogenous genotoxic agents, such as ionizing and UV radiation, DNA topoisomerase I (topotecan) and II (mitoxantrone, etoposide) inhibitors, nitric oxide-releasing aspirin, DNA replication inhibitors (aphidicolin, hydroxyurea, thymidine), and complex environmental carcinogens such as present in tobacco smoke. Also presented is an approach to identify DNA replicating (BrdU incorporating) cells based on selective photolysis of DNA that triggers H2AX phosphorylation. Listed are strategies to distinguish ATM activation and H2AX phosphorylation induced by primary DNA damage by genotoxic agents from those effects triggered by DNA fragmentation that takes place during apoptosis. While we review most published data, recent new findings also are included. Examples of multivariate analysis of ATM activation and H2AX phosphorylation presented in this review illustrate the advantages of cytometric flow- and image-analysis of these events in terms of offering a sensitive and valuable tool in studies of factors that induce DNA damage and/or affect DNA repair and allow one to explore the linkage between DNA damage, cell cycle checkpoints and initiation of apoptosis. Copyright (c) 2007 International Society for Analytical Cytology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17622968      PMCID: PMC3855668          DOI: 10.1002/cyto.a.20426

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  112 in total

Review 1.  The many substrates and functions of ATM.

Authors:  M B Kastan; D S Lim
Journal:  Nat Rev Mol Cell Biol       Date:  2000-12       Impact factor: 94.444

2.  2-deoxy-D-glucose reduces the level of constitutive activation of ATM and phosphorylation of histone H2AX.

Authors:  Toshiki Tanaka; Akira Kurose; H Dorota Halicka; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Cell Cycle       Date:  2006-04-17       Impact factor: 4.534

3.  Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage.

Authors:  Christopher E Helt; William A Cliby; Peter C Keng; Robert A Bambara; Michael A O'Reilly
Journal:  J Biol Chem       Date:  2004-11-08       Impact factor: 5.157

4.  Induction of ATM activation, histone H2AX phosphorylation and apoptosis by etoposide: relation to cell cycle phase.

Authors:  Toshiki Tanaka; H Dorota Halicka; Frank Traganos; Karen Seiter; Zbigniew Darzynkiewicz
Journal:  Cell Cycle       Date:  2007-02-09       Impact factor: 4.534

5.  Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation.

Authors:  G Del Bino; S Bruno; P N Yi; Z Darzynkiewicz
Journal:  Cell Prolif       Date:  1992-11       Impact factor: 6.831

6.  Inhibitory effects of plumbagin and juglone on azoxymethane-induced intestinal carcinogenesis in rats.

Authors:  S Sugie; K Okamoto; K M Rahman; T Tanaka; K Kawai; J Yamahara; H Mori
Journal:  Cancer Lett       Date:  1998-05-15       Impact factor: 8.679

7.  Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines.

Authors:  Judit P Banáth; Susan H Macphail; Peggy L Olive
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

8.  Sequential phosphorylation of Ser-10 on histone H3 and ser-139 on histone H2AX and ATM activation during premature chromosome condensation: relationship to cell-cycle phase and apoptosis.

Authors:  Xuan Huang; Akira Kurose; Toshiki Tanaka; Frank Traganos; Wei Dai; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2006-04       Impact factor: 4.355

9.  The S-phase cytotoxicity of camptothecin.

Authors:  G Del Bino; P Lassota; Z Darzynkiewicz
Journal:  Exp Cell Res       Date:  1991-03       Impact factor: 3.905

10.  An optimized method for detecting gamma-H2AX in blood cells reveals a significant interindividual variation in the gamma-H2AX response among humans.

Authors:  Ismail Hassan Ismail; Tabasum Imran Wadhra; Ola Hammarsten
Journal:  Nucleic Acids Res       Date:  2007-02-06       Impact factor: 16.971

View more
  75 in total

1.  Relationship of DNA damage signaling to DNA replication following treatment with DNA topoisomerase inhibitors camptothecin/topotecan, mitoxantrone, or etoposide.

Authors:  Hong Zhao; Paulina Rybak; Jurek Dobrucki; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2011-12-02       Impact factor: 4.355

2.  Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide.

Authors:  Catherine J Drummond; Graeme J Finlay; Laura Broome; Elaine S Marshall; Emma Richardson; Bruce C Baguley
Journal:  Invest New Drugs       Date:  2010-06-22       Impact factor: 3.850

Review 3.  Laser scanning cytometry for automation of the micronucleus assay.

Authors:  Zbigniew Darzynkiewicz; Piotr Smolewski; Elena Holden; Ed Luther; Mel Henriksen; Maxime François; Wayne Leifert; Michael Fenech
Journal:  Mutagenesis       Date:  2011-01       Impact factor: 3.000

4.  Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies.

Authors:  Eugenio Gaudio; Riccardo Spizzo; Francesco Paduano; Zhenghua Luo; Alexey Efanov; Alexey Palamarchuk; Amanda S Leber; Mohamed Kaou; Nicola Zanesi; Arianna Bottoni; Stefan Costinean; Laura Z Rassenti; Tatsuya Nakamura; Thomas J Kipps; Rami I Aqeilan; Yuri Pekarsky; Francesco Trapasso; Carlo M Croce
Journal:  Blood       Date:  2011-11-07       Impact factor: 22.113

5.  Cell synchronization by inhibitors of DNA replication induces replication stress and DNA damage response: analysis by flow cytometry.

Authors:  Zbigniew Darzynkiewicz; H Dorota Halicka; Hong Zhao; Monika Podhorecka
Journal:  Methods Mol Biol       Date:  2011

6.  Cytometric assessment of DNA damage by exogenous and endogenous oxidants reports aging-related processes.

Authors:  Hong Zhao; Toshiki Tanaka; H Dorota Halicka; Frank Traganos; Miroslaw Zarebski; Jurek Dobrucki; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2007-11       Impact factor: 4.355

7.  Death receptor-induced activation of the Chk2- and histone H2AX-associated DNA damage response pathways.

Authors:  Stéphanie Solier; Olivier Sordet; Kurt W Kohn; Yves Pommier
Journal:  Mol Cell Biol       Date:  2008-10-27       Impact factor: 4.272

8.  Kinetics of the UV-induced DNA damage response in relation to cell cycle phase. Correlation with DNA replication.

Authors:  Hong Zhao; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2010-03       Impact factor: 4.355

9.  Mana-Hox displays anticancer activity against prostate cancer cells through tubulin depolymerization and DNA damage stress.

Authors:  Che-Jen Hsiao; Yunn-Fang Ho; John T-A Hsu; Wei-Ling Chang; Yi-Cheng Chen; Ya-Ching Shen; Ping-Chiang Lyu; Jih-Hwa Guh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-29       Impact factor: 3.000

Review 10.  Emerging metrology for high-throughput nanomaterial genotoxicology.

Authors:  Bryant C Nelson; Christa W Wright; Yuko Ibuki; Maria Moreno-Villanueva; Hanna L Karlsson; Giel Hendriks; Christopher M Sims; Neenu Singh; Shareen H Doak
Journal:  Mutagenesis       Date:  2016-08-26       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.